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Compression moves on: technological and research advances in 
lymphoedema are changing practice and options for patients. 
 
As the average age and BMI of our population continues to rise, nurses in almost all areas of 
healthcare are increasingly faced with managing the heavy limbs and skin problems typical of 
chronic oedema. Any swelling persisting beyond 3 months is defined as chronic oedema (Moffatt et 
al 2003; Lymphoedema Framework 2006) and is indicative of a lymphatic system that is no longer 
able to deal with the fluid load whatever the cause (Mortimer and Rockson 2015). Whilst 
insufficiency of the veins or lymphatics is the primary cause, obesity is a known contributor. More 
worrying still is that lymphoedema brings a 71-fold increased risk of cellulitis over normal (Dupuy et 
al 1999); with 29% having a recurrent episode within 12 months (Moffatt et al 2003). Cellulitis 
admissions already account for 2-3% of all hospital admissions (Halpern et al 2008) and the resultant 
costs are estimated to be in the millions. Research has shown that early identification and 
management of lymphoedema reduces the morbidity, improves outcomes and reduces health and 
social costs (Lacomba et al 2010; Todd et al 2010; Stout et al 2012; Finnane et al 2015). 
In management terms, chronic oedema and lymphoedema are synonymous, but a great deal has 
moved on since almost a decade ago, when I outlined in this journal, the fundamentals of 
compression garments in lymphoedema management (Linnitt and Davies 2007). Our enhanced 
understanding of the physiology and pathology (Mortimer and Rockson 2015) and heightened 
appreciation of the engineering and technical know-how going into today’s compression garments 
(Kimmel 2009) is changing the decision–making process when compression is being considered.  
Nurses have come to understand that compression come in different standards, the original British 
classes being aimed at venous conditions, while more stringent standards apply to lymphoedema 
garment e.g. the German RAL (‘European’ being a common and incorrect misnomer); usefully the 
garments are listed separately in the Drug Tariff. Having established that lymphoedema compression 
garments are appropriate, the next decision is the required prescription of ‘class’ (amount of 
compression  measured in mmHg), here  useful guidelines have been published (Lymphoedema 
Framework 2006; International Society of Lymphology 2013) but all the manufacturers produce 
useful supporting literature and many now have sophisticated online support including free certified 
learning modules. In addition, UK specific online learning resources are permanently available e.g. 
www.lymphoedema-scotland.org   and free introductory courses run periodically (e.g. from 
University of Glasgow). 
Patient-driven changes have included softer fabrics that manage to retain compression and stiffness, 
seamless garments and the vast range of colours now available in lymphoedema garments. But 
arguably the biggest step-change is the suggestion that the stiffness of the garment may in fact be 
more significant than the mmHg of compression applied from elastic material. With this has come an 
increasing array of Velcro-wrap devices, rather like a soft felt-like wet-suit material that wraps 
around the patient’s limb therein being easier to apply and preventing the drag that might cause 
damage to fragile skin. Although arguably no more cosmetically pleasing to wear on a permanent 
daily basis than previous hosiery, the ease of application, adjustability and option to combine with 
existing compression garments have proved popular with nurses and patients alike. With increasing 
recognition that lymphoedema is not just a female problem (Noble-Jones et al 2014; Cooper 2015) 
the wraps’ similarity to an orthopaedic splint gives a high rate of acceptability among male patients 
in our experience.  
Lymphoedema research is now growing at an exponential rate and includes lymph node transplant, 
fluoroscopic diagnostics, personalised exercise prescription, as well as advances in medical devices. 
Most exciting of all is that through organisations such as the Lymphoedema Support Network 
(www.lymphoedema.org) and British Lymphology Society (www.thebls.co.uk) patients, nurses and 
therapists can be involved in this exciting revolution. 
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